IpsenIPSEF 95 OCF Margin % is 30.71% as of Dec. 2025, which is 19% above its 10-year median of 25.90. GuruFocus rates IPSEF with a GF Score™ of 95/100 and a GF Value™ of $92.81. The stock has 7 warning signs investors should review. Among 959 Drug Manufacturers companies, Ipsen ranks better than 91.87% on this metric.
OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Ipsen's Cash Flow from Operations for the
six
months ended in Dec. 2025 was $716 Mil. Ipsen's Revenue for the
six
months ended in Dec. 2025 was $2,333 Mil. Therefore, Ipsen's OCF Margin % for the quarter that ended in Dec. 2025 was 30.71%.
The historical rank and industry rank for Ipsen's OCF Margin % or its related term are showing as below:
IPSEF'
s OCF Margin % Range Over the Past 10 Years
Min: 19.02 Med: 25.9 Max: 32.5
Current: 28.99
During the past 13 years, the highest OCF Margin % of Ipsen was 32.50%. The lowest was 19.02%. And the median was 25.90%.
IPSEF's OCF Margin % is ranked better than 91.87% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs IPSEF: 28.99
Ipsen OCF Margin % Related Terms
Ipsen OCF Margin % Historical Data
* Premium members only.
The historical data trend for Ipsen's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Ipsen's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ipsen OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ipsen's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Ipsen's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ipsen (IPSEF) has a OCF Margin % of 30.71% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Ipsen and its competitors. This is 19% above median its historical median of 25.90. Over the past decade, Ipsen's OCF Margin % has ranged from 19.02 to 32.50. According to the industry distribution chart, Ipsen ranks #78 out of 959 companies in the Drug Manufacturers industry, placing it in the top 8.1%.
Is Ipsen's OCF Margin % too high?
Ipsen's current OCF Margin % of 30.71% is 19% above median its 10-year median of 25.90. Over the past 10 years, this metric has ranged from a low of 19.02 to a high of 32.50. The Drug Manufacturers industry median OCF Margin % is 9.95. Ipsen's value of 30.71% is 208.6% above this industry median. Based on the distribution chart, Ipsen ranks #78 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Ipsen has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Ipsen's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ipsen ranks #78 out of 959 companies for OCF Margin %. This places Ipsen in the top 8% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.95. Ipsen's value of 30.71% is 208.6% above this benchmark. Historically, Ipsen's own OCF Margin % has ranged from 19.02 to 32.50 over the past decade. While the company's 10-year median is 25.90 vs. the industry median of 9.95, Ipsen has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ipsen's current OCF Margin % of 30.71% is 208.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Ipsen and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ipsen's current OCF Margin % is 30.71%, which is 19% above median its own 10-year median of 25.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ipsen stock overvalued right now?
Ipsen (IPSEF) has a current OCF Margin % of 30.71%. The stock's GF Value™ is $92.81, compared to a current price of $113.13 — trading 21.9% above its estimated fair value. The current OCF Margin % is 30.71%, which is 19% above median its 10-year median of 25.90 and 208.6% above the Drug Manufacturers industry median of 9.95. Ipsen's overall GF Score™ is 95/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Ipsen (IPSEF), the current OCF Margin % is 30.71% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ipsen (IPSEF) Overvalued in 2026?
Based on GuruFocus' analysis, Ipsen stock appears to be overvalued.
The current stock price of $113.13 is trading 21.9% above its estimated GF Value™ of $92.81.
Key valuation signals for IPSEF:
OCF Margin %: 30.71% (19% above median its 10-year median of 25.90)
GF Value™: $92.81 vs. price of $113.13 (21.9% above fair value)
Industry Position: 208.6% above the Drug Manufacturers median (#78 of 959)
No single metric tells the full story. See the IPSEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders, but in February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for only 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 20 drugs in 115 countries.
95GF Score
Get the complete analysis for IPSEF
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IPSEF has been successfully added to your 
